A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer

Clinical trial NCT05275673 · TERMINATED

Trial details

NCT number: NCT05275673
Sponsor: Faeth Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Squamous Non-small-cell Lung Cancer Squamous Non-Small Cell Neoplasm of Lung NFE2L2 Gene Mutation

Start date: 2022-07-21
Primary completion: 2023-01-24
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.